Boris E. Polotsky
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy.
Journal: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]
Published: August 01, 2016
Flow cytometric analysis of the ERCC1, marker of DNA damage repair, in the tumor specimens embedded into paraffin blocks.
Journal: Doklady. Biochemistry and biophysics
Published: July 26, 2016
Digoxin is a selective modifier increasing platinum drug anticancer activity.
Journal: Doklady. Biochemistry and biophysics
Published: February 20, 2016
PROSPECTIVE SYNTHETIC MATRICES FOR THE RECONSTRUCTION OF TRACHEAL DEFECTS IN CANCER PATIENTS
Journal: Voprosy onkologii
Published: August 06, 2015
Therapeutic approaches to gastroesophageal junction adenocarcinomas.
Journal: Annals of the New York Academy of Sciences
Published: October 01, 2014
Comparative assessment of the estrogen receptor β expression in the tissues of non-small cell lung carcinoma and lung metastases of tumors of other primary localizations.
Journal: Doklady. Biochemistry and biophysics
Published: October 28, 2013
Tamoxifen non-estrogen receptor mediated molecular targets.
Journal: Oncology reviews
Published: March 22, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026